Khodr Issa, BSc (2007), MSc (2009), PhD (2013)


Dr. Khodr Issa holds a BSc in Molecular Biology and Biochemistry (2007) from the University of Henri Poincare, Nancy 1 (France), a MSc in Bioengineering and Pharmacology (2009) from the University of Henri Poincare, Nancy 1 (France) and a PhD in Biology and Health (2013) from University of Lorraine (France) with title “Protector effect of hydrogen sulfide (H2S), Activated protein C (APC) and dexamethasone (Dexa) in hemodynamic and inflammatory modulation of ischemia-reperfusion”, also qualified with significant skills and expertise in experimental surgery and animal care. He worked as a PhD student and then as an Associate Researcher (2009-2013) at the laboratory of DCAC (U1116 UMG, Nancy, France) that belongs to INSERM (National Institute of Health and Medical Research). He started his post-doc working in EPOS-Iasis in 2013 and he is currently working on a European Marie-Curie project funding (NANORESISTANCE) with title “Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems”. His research interests were focused in the animal experimentation (design and implement new preclinical orthotopic models) – advanced molecular imaging and biomedical engineering modalities such as micro-endoscopy and image-guided orthotopic implantation – molecular pathophysiology and developed new approaches in molecular pharmacology of diverse nanoparticulate systems, thus engaging into active and productive interaction with consortium experts in material sciences and organic chemistry – cell culture (cancer stem cells).